Shire: a tempting buy-out bet
Pharmaceuticals firm Shire is set to be taken over – but it’s cheap even if the deal fails.
If you’d invested in: Dechra Pharmaceuticals and Shire
Dechra Pharmaceuticals is a drugs company that specialises in the development of medical treatments for pets. Over the next three years, the firm’s ea…
Three stocks to profit from the boom in pharma M&A
Ailsa Craig picks three stocks that should capitalise on the M&A trend in the pharmaceutical sector, either as potential targets or as well-establishe…
Pocket some grey pounds – three healthcare stocks to buy now
The ageing population is an opportunity for the health and medical sector. Here, professional investor Garry White picks three healthcare stocks to bu…
Shire’s $30bn move on Baxalta
Pharma giant Shire has made an unsolicited $30bn all-share offer for America’s Baxalta.
UK stocks ahead as investor shrug off fresh oil price drop
Investors have shrugged off concerns over the falling price of oil this morning ahead of the release of US earnings data.